Subtyping of triple-negative breast cancer: Implications for therapy

Author： Abramson Vandana G.   Lehmann Brian D.   Ballinger Tarah J.   Pietenpol Jennifer A.  

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|121|1|8-16

ISSN： 0008-543X

Source： Cancer, Vol.121, Iss.1, 2015-01, pp. : 8-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Triple-Negative Breast Cancer: Epidemiology and Management Options

By Dawood Shaheenah  

Drugs, Vol. 70, Iss. 17, 2010-12 ,pp. : 2247-2258

Adis International

Access to resources Recommend Favorite

Advances in the Treatment of Triple-negative Early Breast Cancer

By  

Medicinal Chemistry, Vol. 12, Iss. 3, 2016-05 ,pp. : 268-272

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Approaches to Triple-Negative Breast Cancer: Current Practice and Future Directions

By  

Current Medicinal Chemistry, Vol. 20, Iss. 5, 2013-02 ,pp. : 605-612

Bentham Science Publishers

Access to resources Recommend Favorite

Toxicity and efficacy evaluation of multiple targeted polymalic acid conjugates for triple-negative breast cancer treatment

By Ljubimova Julia Y.   Portilla-Arias Jose   Patil Rameshwar   Ding Hui   Inoue Satoshi   Markman Janet L.   Rekechenetskiy Arthur   Konda Bindu   Gangalum Pallavi R.   Chesnokova Alexandra   Ljubimov Alexander V.   Black Keith L.   Holler Eggehard  

Journal of Drug Targeting, Vol. 21, Iss. 10, 2013-12 ,pp. : 956-967

Informa Healthcare

Access to resources Recommend Favorite

Active smoking and the risk of estrogen receptor-positive and triple-negative breast cancer among women ages 20 to 44 years

By Kawai Masaaki   Malone Kathleen E.   Tang Mei-Tzu C.   Li Christopher I.  

Cancer, Vol. 120, Iss. 7, 2014-04 ,pp. : 1026-1034

Blackwell Publishing

Access to resources Recommend Favorite